Skip to main content

Topoisomerase II-Catalyzed ATP Hydrolysis as Monitored by Thin-Layer Chromatography

  • Protocol
DNA Topoisomerase Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 95))

  • 909 Accesses

Abstract

Although type I topoisomerases do not require a high-energy cofactor, type II topoisomerases require ATP in order to carry out their essential catalytic functions (14). ATP binding is necessary to close the protein clamp (5,6) and trigger DNA strand passage (7,8), whereas hydrolysis is necessary for topoisomerase II recycling (7,8). Beyond the the critical roles played by ATP in the catalytic cycle of the enzyme, interactions between type II topoisomerases and ATP are also affected by compounds with antimicrobial and anticancer properties. For example, coumarin-based antimicrobials block DNA gyrase function specifically by inhibiting ATP hydrolysis (711). In addition, several anticancer drugs that act by enhancing topoisomerase II-mediated DNA cleavage also impair interactions between the enzyme and ATP (12).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Osheroff N., Zechiedrich E. L., and Gale K. C. (1991) Catalytic function of DNA topoisomerase II. BioEssays 13, 269–273.

    Article  PubMed  CAS  Google Scholar 

  2. Watt P. M. and Hickson I. D. (1994) Structure and function of type II DNA topoisomerases. Biochem. J. 303, 681–695.

    PubMed  CAS  Google Scholar 

  3. Wang J. C. (1996) DNA topoisomerases. Annu. Rev. Biochem. 65, 635–692.

    Article  PubMed  CAS  Google Scholar 

  4. Burden D. A. and Osheroff N. (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochem. Biophys. Acta. 1400, 139–154.

    PubMed  CAS  Google Scholar 

  5. Osheroff N. (1986) Eukaryotic topoisomerase II. Characterization of enzyme turnover. J. Biol. Chem. 261, 9944–9950.

    PubMed  CAS  Google Scholar 

  6. Roca J. and Wang J. C. (1992) The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases. Cell 71, 833–840.

    Article  PubMed  CAS  Google Scholar 

  7. Sugino A., Higgins N. P., Brown P. O., Peebles C. L., and Cozzarelli N. R. (1978) Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc. Natl. Acad. Sci. USA 75, 4838–4842.

    Article  PubMed  CAS  Google Scholar 

  8. Osheroff N., Shelton E. R., and Brutlag D. L. (1983) DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA. J. Biol. Chem. 258, 9536–9543.

    PubMed  CAS  Google Scholar 

  9. Mizuuchi K., OsDea M. H., and Gellert M. (1978) DNA gyrase: Subunit structure and ATPase activity of the purified enzyme. Proc. Natl. Acad. Sci. USA 75, 5960–5963.

    Article  PubMed  CAS  Google Scholar 

  10. Goto T. and Wang J. C. (1982) Yeast DNA topoisomerase II. An ATP-dependent type II topoisomerase that catalyzes the catenation, decatenation, unknotting, and relaxation of double-stranded DNA rings. J. Biol. Chem. 257, 5866–5872.

    PubMed  CAS  Google Scholar 

  11. Maxwell A. (1993) The interaction between coumarin drugs and DNA gyrase. Mol. Microbiol. 9, 681–686.

    Article  PubMed  CAS  Google Scholar 

  12. Robinson M. J., Corbett A. H., and Osheroff N. (1993) Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Biochemistry 32, 3638–3643.

    Article  PubMed  CAS  Google Scholar 

  13. Sugino A. and Cozzarelli N. R. (1980) The intrinsic ATPase of DNA gyrase. J. Biol. Chem. 255, 6299–6306.

    PubMed  CAS  Google Scholar 

  14. Maxwell A. and Gellert M. (1984) The DNA dependence of the ATPase activity of DNA gyrase. J. Biol. Chem. 259, 14,472–14,480.

    PubMed  CAS  Google Scholar 

  15. Ali J. A., Jackson A. P., Howells A. J., and Maxwell A. (1993) The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 32, 2717–2724.

    Article  PubMed  CAS  Google Scholar 

  16. Lindsley J. E. and Wang J. C. (1993) On the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II. J. Biol. Chem. 268, 8096–8104.

    PubMed  CAS  Google Scholar 

  17. Halligan B. D., Edwards K. A., and Liu L. F. (1985) Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. J. Biol. Chem. 260, 2475–2482.

    PubMed  CAS  Google Scholar 

  18. Schomburg U. and Grosse F. (1986) Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. Eur. J. Biochem. 160, 451–457.

    Article  PubMed  CAS  Google Scholar 

  19. Osheroff N. (1987) Role of the divalent cation in topoisomerase II mediated reactions. Biochemistry 26, 6402–6406.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Humana Press Inc.

About this protocol

Cite this protocol

Kingma, P.S., Fortune, J.M., Osheroff, N. (2001). Topoisomerase II-Catalyzed ATP Hydrolysis as Monitored by Thin-Layer Chromatography. In: Osheroff, N., Bjornsti, MA. (eds) DNA Topoisomerase Protocols. Methods in Molecular Biology™, vol 95. Humana Press. https://doi.org/10.1385/1-59259-057-8:51

Download citation

  • DOI: https://doi.org/10.1385/1-59259-057-8:51

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-512-6

  • Online ISBN: 978-1-59259-057-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics